Genitourinary Cancer

PV QA 1 - Poster Viewing Q&A 1

SU_21_2215 - Improvement in Recurrence-free Survival with Adjuvant Radiation in Adrenocortical Carcinoma

Sunday, October 21
1:15 PM - 2:45 PM
Location: Innovation Hub, Exhibit Hall 3

Improvement in Recurrence-free Survival with Adjuvant Radiation in Adrenocortical Carcinoma
L. A. Gharzai1, M. Green1, K. Griffith2, T. Else3, D. E. Spratt1, B. Miller4, F. Worden5, G. D. Hammer3, T. Giordano6, E. Hesseltine3, A. Sabolch7, E. Ben-Josef8, and S. Jolly1; 1Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, 2Department of Biostatistics, University of Michigan, Ann Arbor, MI, 3Department of Endocrinology, University of Michigan, Ann Arbor, MI, 4Department of Surgery, University of Michigan, Ann Arbor, MI, 5Department of Internal Medicine, Division of Medical Oncology, University of Michigan, Ann Arbor, MI, 6Department of Pathology, University of Michigan, Ann Arbor, MI, 7Department of Radiation Oncology, Kaiser Permanente, Portland, OR, 8Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA

Purpose/Objective(s): Adrenocortical carcinoma (ACC) is a rare malignancy with high rates of local recurrence and poor prognosis. Given high propensity to metastasize, the role of post-operative radiation therapy (RT) in localized ACC has been controversial. We sought to evaluate the benefit of adjuvant RT to local control in our updated institutional ACC database.

Materials/Methods: From 424 patients in our ACC database, we retrospectively identified patients who underwent adjuvant RT at our institution from 1999 to 2017. Patients that were treated with surgery followed by adjuvant RT were matched to patients who only underwent resection on the basis of stage, surgical margin status, tumor grade, and adjuvant mitotane use. Local recurrence was defined as adrenal bed or abdominal failure. Overall and recurrence-free survival probabilities were estimated using the Kaplan-Meier method. Distributions were compared between cases and controls using the log-rank test statistic. Cox proportional hazards regression models were used to estimate the hazard ratio for time-to-event endpoints comparing controls to cases after adjustment for age at event and gender.

Results: Of 424 patients, 78 patients with ACC were selected, half who underwent adjuvant radiation. Patients were matched 1:1 without significant differences with respect to stage, margin status, grade, or mitotane use, although there were more females than males in the matched group (52.8% females with RT, 82% without RT). Median radiation dose was 55 Gy (range 45-60 Gy). Local recurrence was less common with adjuvant RT (13 vs 26 local failures in those treated with and without RT, respectively, (p = 0.038, hazard ratio [HR] 2.20; 95% confidence interval [CI] 1.04-4.63)). Five-year recurrence-free survival for patients with RT was 46.7% and 16.9% for patients without (p = 0.016; HR 2.32, 95% CI 1.14-4.57). There was numerically better overall survival in patients that received RT (72.1% versus 55.1%), although this was not statistically significant (p = 0.424, HR 1.46, 95% CI 0.58-3.68).

Conclusion: Adjuvant RT following gross resection of ACC significantly improves recurrence free-survival in this retrospective case-matched cohort analysis. Even though, this represents the largest series to date on adjuvant RT for ACC, prospective confirmation of this data is needed.

Author Disclosure: L.A. Gharzai: None. M. Green: None. K. Griffith: None. T. Else: None. B. Miller: None. F. Worden: Research Grant; Bristol Myers Squibb. Honoraria; Bristol Myers Squibb, Merck. Advisory Board; Bristol Myers Squibb, Genzyme, Merck. E. Hesseltine: None. A. Sabolch: None. E. Ben-Josef: member; NCI Board of Sceintific Counselors. Board member; NCI Board os Scientific Counselors.

Laila Gharzai, MD

Presentation(s):

Send Email for Laila Gharzai


Assets

SU_21_2215 - Improvement in Recurrence-free Survival with Adjuvant Radiation in Adrenocortical Carcinoma



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Improvement in Recurrence-free Survival with Adjuvant Radiation in Adrenocortical Carcinoma